PMID: 2495020Feb 1, 1989Paper

Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin

British Journal of Obstetrics and Gynaecology
W H MattaM Nye

Abstract

Ten patients with uterine fibroids palpable abdominally were treated with the luteinizing hormone-releasing hormone (LHRH) agonist buserelin, administered intransally, 300 micrograms three times daily, for 6 months, and were then followed for a further 12 months. Oestrogen levels were markedly reduced in all patients during treatment. At the end of treatment the mean volume reductions were 44.4% (SEM 3.5) for total uterine volume and 57.3% (SEM 7.4) for volume of discrete fibroids as assessed ultrasonically. There was also marked improvement in associated symptoms. After buserelin therapy was stopped, the total uterine and discrete fibroid volumes returned to, or slightly exceeded, pretreatment volumes within 6 months in five patients, and by 12 months in two patients. Three other patients who underwent surgery for their fibroids during the first 4 months after treatment showed regrowth of fibroids to pretreatment size. Four comparable asymptomatic untreated patients showed no significant change in the total uterine or fibroid volume during six monthly ultrasonic assessments. Buserelin therapy may facilitate rather than replace surgery in the management of uterine fibroids.

References

May 1, 1986·Fertility and Sterility·C C CoddingtonC A Winkel
Oct 1, 1986·American Journal of Obstetrics and Gynecology·E M CoutinhoM T Gonçalves
Aug 15, 1985·American Journal of Obstetrics and Gynecology·R MaheuxA T Fazekas
Jan 1, 1985·Acta Obstetricia Et Gynecologica Scandinavica·T TamayaH Okada
Apr 1, 1974·Endocrinology·R ResnikG Meschia
Nov 1, 1970·Journal of Clinical Pathology·L Deligdish, M Loewenthal
Sep 1, 1984·British Journal of Obstetrics and Gynaecology·R W Shaw, H M Fraser
May 1, 1982·American Journal of Obstetrics and Gynecology·M R Soules, K S McCarty
Dec 1, 1949·The Journal of Clinical Endocrinology and Metabolism·A SEGALOFF, J C WEED

❮ Previous
Next ❯

Citations

Jul 25, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A M FranssenR Rolland
Jan 4, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L FedeleL Bocciolone
Feb 19, 1999·Baillière's Clinical Obstetrics and Gynaecology·R W Shaw
Nov 28, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·Cynthia FarquharSue Furness
Jan 20, 1991·The New England Journal of Medicine·P M Conn, W F Crowley
Mar 25, 1993·The New England Journal of Medicine·K J CarlsonI Schiff
Feb 3, 2012·The New England Journal of Medicine·Jacques DonnezUNKNOWN PEARL I Study Group
May 12, 2001·Clinical Obstetrics and Gynecology·N F Chavez, E A Stewart
Jul 20, 2013·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Avner ShemerHaim Azhari
Apr 1, 1990·British Journal of Obstetrics and Gynaecology·B J VollenhovenD L Healy
May 1, 1990·British Journal of Obstetrics and Gynaecology·L FedeleM Dorta
Feb 1, 1992·British Journal of Obstetrics and Gynaecology·G BenagianoF M Primiero
Jan 12, 2012·BMC Women's Health·Dominique N MarkowskiJörn Bullerdiek
Jun 10, 2008·Gynécologie, obstétrique & fertilité·C MalarticE Barranger
Sep 10, 2003·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·A ImaiT Tamaya
Mar 7, 2008·Expert Opinion on Emerging Drugs·Ming-Huei Cheng, Peng-Hui Wang
Jul 4, 2009·Taiwanese Journal of Obstetrics & Gynecology·Peng-Hui WangHsiang-Tai Chao
Feb 19, 1999·Baillière's Clinical Obstetrics and Gynaecology·J Crow
Mar 1, 1997·Baillière's Clinical Obstetrics and Gynaecology·A Davies, A L Magos
Aug 7, 2013·Expert Opinion on Pharmacotherapy·Friederike HoellenMichael K Bohlmann
Oct 19, 2016·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Kae HachiyaMasayuki Matsuo
Mar 14, 2009·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Madhu BagariaKiran Mishra
Feb 1, 1992·British Journal of Obstetrics and Gynaecology·D L Healy, B J Vollenhoven
Mar 17, 2004·Menopause : the Journal of the North American Menopause Society·Susan D ReedStephen M Schwartz
Mar 1, 2006·Obstetrics and Gynecology Clinics of North America·Melissa K LobelCynthia C Morton
Oct 26, 2001·The Journal of the American Association of Gynecologic Laparoscopists·V DoridotK Babaki-Fard
Jul 17, 2001·The Australian & New Zealand Journal of Obstetrics & Gynaecology·C FarquharUNKNOWN Working Party of the New Zealand Guidelines Group
Oct 31, 2001·Histopathology·N Wilkinson, T P Rollason
Jun 3, 2004·Obstetrics and Gynecology·Jody SteinauerAlison F Jacoby
Jun 1, 1996·British Journal of Obstetrics and Gynaecology·C J Sutton
Sep 12, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Vincenzo De LeoFelice Petraglia
Oct 19, 2012·The Cochrane Database of Systematic Reviews·Linyu DengJinrong Yang
Nov 30, 2019·Archives of Gynecology and Obstetrics·Xiu MingZheng Yu Li
Dec 1, 1992·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·V Aleandri, G Benagiano
Jun 19, 2001·The Cochrane Database of Systematic Reviews·A LethabyM Sowter
Feb 5, 2009·BJOG : an International Journal of Obstetrics and Gynaecology·N Al-ShabibiA Magos
Nov 16, 2017·The Cochrane Database of Systematic Reviews·Anne LethabyBeverley Vollenhoven

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.